Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company — potentially changing the lives of millions of people.
4 November 2022
Groundbreaking UQ research into developing new treatments for conditions such as cancer, inflammatory diseases and type 1 diabetes has received recognition and funding support from a national incubator for biomedical startup companies.
20 July 2022
